Literature DB >> 26116714

Spontaneous ventricular tachyarrhythmias in β2-adrenoceptor transgenic mice in relation to cardiac interstitial fibrosis.

My-Nhan Nguyen1, Helen Kiriazis2, Diego Ruggiero3, Xiao-Ming Gao1, Yidan Su2, Anne Jian2, Li-Ping Han4, Julie R McMullen5, Xiao-Jun Du6.   

Abstract

Myocardial fibrosis is regarded as a pivotal proarrhythmic substrate, but there have been no comprehensive studies showing a correlation between the severity of fibrosis and ventricular tachyarrhythmias (VTAs). Our purpose was to document this relationship in a transgenic (TG) strain of mice with fibrotic cardiomyopathy. TG mice with cardiac overexpression of β2-adrenoceptors (β2-AR mice) and non-TG (NTG) littermates were studied at 4-12 mo of age. VTA was quantified by ECG telemetry. The effect of pharmacological blockade of β2-ARs on VTA was examined. Myocardial collagen content was determined by hydroxyproline assay. NTG and TG mice displayed circadian variation in heart rate, which was higher in TG mice than in NTG mice (P <0.05). Frequent spontaneous ventricular ectopic beats (VEBs) and ventricular tachycardia (VT) were prominent in TG mice but not present in NTG mice. The frequency of VEB and VT episodes in TG mice increased with age (P < 0.01). Ventricular collagen content was greater in TG mice than in NTG mice (P <0.001) and correlated with age (r = 0.71, P < 0.01). The number of VEBs or VT episodes correlated with age (r = 0.83 and r = 0.73) and the content of total or cross-linked collagen (r = 0.62∼0.66, all P <0.01). While having no effect in younger β2-TG mice, β2-AR blockade reduced the frequency of VTA in old β2-TG mice with more severe fibrosis. In conclusion, β2-TG mice exhibit interstitial fibrosis and spontaneous onset of VTA, becoming more severe with aging. The extent of cardiac fibrosis is a major determinant for both the frequency of VTA and proarrhythmic action of β2-AR activation.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  fibrosis; telemetry; ventricular tachyarrhythmias; β-adrenergic receptor

Mesh:

Substances:

Year:  2015        PMID: 26116714     DOI: 10.1152/ajpheart.00405.2015

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  14 in total

Review 1.  β-Adrenoceptor activation affects galectin-3 as a biomarker and therapeutic target in heart disease.

Authors:  Xiao-Jun Du; Wei-Bo Zhao; My-Nhan Nguyen; Qun Lu; Helen Kiriazis
Journal:  Br J Pharmacol       Date:  2019-04-07       Impact factor: 8.739

2.  Cardiac fibrosis in oncologic therapies.

Authors:  René R Sevag Packard
Journal:  Curr Opin Physiol       Date:  2022-08-08

Review 3.  The emerging role of leptin in obesity-associated cardiac fibrosis: evidence and mechanism.

Authors:  Yukang Mao; Kun Zhao; Peng Li; Yanhui Sheng
Journal:  Mol Cell Biochem       Date:  2022-10-10       Impact factor: 3.842

Review 4.  Adrenergic signaling in heart failure and cardiovascular aging.

Authors:  Gaetano Santulli; Guido Iaccarino
Journal:  Maturitas       Date:  2016-03-26       Impact factor: 4.342

Review 5.  Cardiac fibrosis.

Authors:  Nikolaos G Frangogiannis
Journal:  Cardiovasc Res       Date:  2021-05-25       Impact factor: 10.787

6.  Mechanisms responsible for increased circulating levels of galectin-3 in cardiomyopathy and heart failure.

Authors:  My-Nhan Nguyen; Yidan Su; Donna Vizi; Lu Fang; Andris H Ellims; Wei-Bo Zhao; Helen Kiriazis; Xiao-Ming Gao; Junichi Sadoshima; Andrew J Taylor; Julie R McMullen; Anthony M Dart; David M Kaye; Xiao-Jun Du
Journal:  Sci Rep       Date:  2018-05-29       Impact factor: 4.379

7.  Cardiac β-adrenergic receptor activation mediates distinct and cell type-dependent changes in the expression and distribution of connexin 43.

Authors:  Yi Zhang; Meng-Chen Hou; Jing-Jing Li; Ying Qi; Yu Zhang; Gang She; Yu-Jie Ren; Wei Wu; Zheng-Da Pang; Wenjun Xie; Xiu-Ling Deng; Xiao-Jun Du
Journal:  J Cell Mol Med       Date:  2020-06-24       Impact factor: 5.310

8.  Stimulation of β-adrenoceptors up-regulates cardiac expression of galectin-3 and BIM through the Hippo signalling pathway.

Authors:  Wei-Bo Zhao; Qun Lu; My-Nhan Nguyen; Yidan Su; Mark Ziemann; Li-Na Wang; Helen Kiriazis; Hamsa Puthalakath; Junichi Sadoshima; Hou-Yuan Hu; Xiao-Jun Du
Journal:  Br J Pharmacol       Date:  2019-05-30       Impact factor: 8.739

9.  Partial Mechanical Unloading of the Heart Disrupts L-Type Calcium Channel and Beta-Adrenoceptor Signaling Microdomains.

Authors:  Peter T Wright; Jose L Sanchez-Alonso; Carla Lucarelli; Anita Alvarez-Laviada; Claire E Poulet; Sean O Bello; Giuseppe Faggian; Cesare M Terracciano; Julia Gorelik
Journal:  Front Physiol       Date:  2018-09-19       Impact factor: 4.566

Review 10.  New Insights in Cardiac β-Adrenergic Signaling During Heart Failure and Aging.

Authors:  Claudio de Lucia; Akito Eguchi; Walter J Koch
Journal:  Front Pharmacol       Date:  2018-08-10       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.